Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00373399 · ClinicalTrials.gov registry record · Phase 1
Effects of Smoked Marijuana on Risk Taking and Decision Making Tasks
A Phase 1 study, sponsored by New York State Psychiatric Institute.
- Completed
- Registry status
- Phase 1
- Development phase
- 36
- Enrollment target
NCT00373399: Completed Phase 1 study, sponsored by New York State Psychiatric Institute.
NCT00373399 is a Phase 1 study that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 36 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (40% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00373399, a Phase 1 study, has completed, sponsored by New York State Psychiatric Institute.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 36 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate the effects of smoked marijuana on both risk taking and decision making tasks.
Primary Outcome
A modified version of the Gambling Task (Bechara et al., 1994) was used. Four decks of cards (A-D) were displayed on a computer screen. Volunteers were told that the objective of the game was to win as much money as possible. They were also told that the game entailed a series of card selections from any of the decks, one card at a time, and that they should select cards until instructed to stop. The task was stopped after 100 card selections or after 5 min had elapsed. Data indicate change from
Interventions
- DRUG Inactive Marijuana (0% THC)
- DRUG Low THC marijuana (1.8 %THC)
- DRUG High THC marijuana (3.9% THC)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2006-05 |
| Est. Completion | 2008-03 |
| Phase | Phase 1 |
What the finished NCT00373399 record still lists
NCT00373399 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (40% lower).
The record links to 0 conditions, and to 3 interventions - of which Inactive Marijuana (0% THC) is the first listed.
NCT00373399 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00373399 about?
NCT00373399 is a clinical study titled "Effects of Smoked Marijuana on Risk Taking and Decision Making Tasks". The purpose of this study is to investigate the effects of smoked marijuana on both risk taking and decision making tasks.
What is the current status of trial NCT00373399?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 36 participants. The study started on 2006-05. Estimated completion is 2008-03.
What interventions are being tested in trial NCT00373399?
The interventions under investigation include: Inactive Marijuana (0% THC) (DRUG), Low THC marijuana (1.8 %THC) (DRUG), High THC marijuana (3.9% THC) (DRUG).
Who is sponsoring clinical trial NCT00373399?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00373399's enrollment target sits among peer trials
36 1210th of 2000 higher than 743 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia